Capital Research Global Investors - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 169 filers reported holding GW PHARMACEUTICALS PLC in Q4 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Capital Research Global Investors ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$9,049,000
-97.9%
41,719
-98.9%
0.00%
-98.2%
Q4 2020$431,196,000
+18.7%
3,736,209
+0.1%
0.11%
+2.8%
Q3 2020$363,380,000
-20.1%
3,732,712
+0.7%
0.11%
-24.3%
Q2 2020$455,004,000
+40.2%
3,707,662
+0.0%
0.14%
+13.4%
Q1 2020$324,631,000
-14.3%
3,707,103
+2.3%
0.13%
+11.4%
Q4 2019$378,824,000
-8.7%
3,623,067
+0.4%
0.11%
-16.2%
Q3 2019$415,072,000
-33.3%
3,608,370
+0.0%
0.14%
-31.0%
Q2 2019$621,951,000
+2.3%
3,607,812
+0.0%
0.20%
+2.1%
Q1 2019$608,061,000
+73.1%
3,607,171
+0.0%
0.19%
+58.2%
Q4 2018$351,302,000
-39.8%
3,607,168
+6.9%
0.12%
-27.8%
Q3 2018$583,098,000
+23.8%
3,375,580
-0.0%
0.17%
+31.0%
Q2 2018$471,049,000
+23.9%
3,375,724
+0.0%
0.13%
+19.4%
Q1 2018$380,328,000
-14.7%
3,375,5960.0%0.11%
-17.6%
Q4 2017$445,612,000
+44.4%
3,375,596
+11.0%
0.13%
+40.9%
Q3 2017$308,568,000
+1.8%
3,040,380
+0.5%
0.09%
-2.1%
Q2 2017$303,214,000
-16.9%
3,024,580
+0.2%
0.10%
-17.4%
Q1 2017$364,949,000
+8.2%
3,017,6040.0%0.12%
+5.5%
Q4 2016$337,217,000
-15.8%
3,017,6040.0%0.11%
-17.4%
Q3 2016$400,527,000
+66.5%
3,017,604
+14.9%
0.13%
+61.0%
Q2 2016$240,525,000
+27.7%
2,626,674
+0.6%
0.08%
+26.2%
Q1 2016$188,360,000
+3.9%
2,610,6740.0%0.06%
+4.8%
Q4 2015$181,285,000
-24.0%
2,610,6740.0%0.06%
-27.1%
Q3 2015$238,537,000
-25.2%
2,610,674
+0.6%
0.08%
-19.0%
Q2 2015$318,877,000
+70.6%
2,595,874
+26.5%
0.10%
+64.1%
Q1 2015$186,933,000
+34.6%
2,051,2740.0%0.06%
+36.2%
Q4 2014$138,830,000
-16.2%
2,051,274
+0.1%
0.05%
-17.5%
Q3 2014$165,647,000
-17.1%
2,048,820
+10.0%
0.06%
-18.6%
Q2 2014$199,892,000
+316.4%
1,863,100
+130.4%
0.07%
+311.8%
Q1 2014$48,001,000808,5000.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2016
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders